TAMPA, Fla., Nov. 22, 2004 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC) Semi-Annual letter to shareholders by CEO Peter Fiorillo:
Dear Shareholders,
Rx Processing Corp. is focused on improving its fundamentals over the next fiscal year. In 2004, we have achieved the following results; Acquired Canada Drugs of Spring Hill, secured major contracts (Liberty Benefits / Lab Pass Solutions), expanded the Sales and Marketing Team, implemented a new IT infrastructure, serviced over 50,000 clients network-wide, expanded the number of company and Affiliate owned storefronts to 130, contracted with independent American pharmacies, reduced our clients' costs of American generic drugs and began branding Rx Processing Corp. nationally. These accomplishments were achieved due to the persistence and focus of you, our dedicated employees, management and shareholders.
As CEO, I have led the Company in a competitive industry and have often had to make difficult decisions in order to continue positioning Rx Processing as a beacon of hope for the millions of U.S. Citizens without access to safe and affordable prescription drugs. On the challenging road ahead, our leadership is tasked with fulfilling the needs of our clients, abiding by and working with government and industry officials to ensure continued access to safe, affordable prescription drugs. The Company has adopted the acronym "ACES" to guide our leaders on the road ahead.
A: 'Assurance' Providing assurance to the public that we are an ethically motivated corporation
C: 'Compliance' Maintaining full regulatory governmental compliance with all issues
E: 'Efficacy' Facilitating the distribution of effective name brand and generic drugs
S: 'Safety' Our lone mission is to assure the distribution of proven safe Government approved medications
In 2005, Rx Processing Corp's goals are expansion to 50 company owned storefronts, the servicing of an additional 100,000 new clients and listing the company on the American Stock Exchange.
To all employees, management, shareholders, and clients, I thank you for the opportunity to lead Rx Processing Corp. and assure you that we will continue down the path of success into 2005.
Sincerely,
Peter Fiorillo
CEO
Rx Processing Corp
P.S. Happy Thanksgiving
Americans who have no prescription insurance coverage have turned to Rx Processing, which offers FDA approved American generic and low-cost Canadian brand name drugs. Rx Processing's state-of-the-art technology finds the best prescription drug prices for these customers by sending their prescriptions to licensed pharmacies to be filled. Rx Processing provides access to prescription drugs for the 40 million Americans without prescription drug coverage that spend billions of dollars on their prescription drugs per year.
Rx Processing is rapidly becoming a market leader in providing prescription drugs to U.S. Citizens, corporations, unions, and prescription benefit plans through licensed pharmacies in the United States and Canada. The Company provides access to over 1,500 approved name brand and generic medications ready for distribution in the U.S. market through its Company owned and operated storefront locations and over 130 affiliated storefronts. By utilizing Rx Processing, U.S. citizens can save up to 84% on their daily prescriptions. These reduced cost medications are available at the Company's affiliate retail storefronts and information about the company can be found at www.rxprocessingcorp.com
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.